Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea

被引:90
作者
Bankir, Lise [1 ,2 ]
Roussel, Ronan [1 ,2 ,3 ]
Bouby, Nadine [1 ,2 ]
机构
[1] Ctr Rech Cordeliers, INSERM, UMRS 1138, F-75006 Paris, France
[2] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France
[3] Hop Bichat Claude Bernard, AP HP, DHU FIRE, Diabetol Endocrinol Nutr, F-75877 Paris, France
关键词
nitrogen excretion; amino acid; urine concentration; tubuloglomerular feedback; thick ascending limb; ATRIAL-NATRIURETIC-PEPTIDE; PERFUSED-RAT-LIVER; THICK ASCENDING LIMB; AMINO-ACID INFUSION; CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; SELECTIVE CONCENTRATING DEFECT; TRANSPORTER KNOCKOUT MICE; FILTRATION-RATE; DIETARY-PROTEIN;
D O I
10.1152/ajprenal.00614.2014
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
A single protein-rich meal (or an infusion of amino acids) is known to increase the glomerular filtration rate (GFR) for a few hours, a phenomenon known as "hyperfiltration." It is important to understand the factors that initiate this upregulation because it becomes maladaptive in the long term. Several mediators and paracrine factors have been shown to participate in this upregulation, but they are not directly triggered by protein intake. Here, we explain how a rise in glucagon and in vasopressin secretion, directly induced by protein ingestion, might be the initial factors triggering the hepatic and renal events leading to an increase in the GFR. Their effects include metabolic actions in the liver and stimulation of sodium chloride reabsorption in the thick ascending limb. Glucagon is not only a gluco-regulatory hormone. It is also important for the excretion of nitrogen end products by stimulating both urea synthesis in the liver (along with gluconeogenesis from amino acids) and urea excretion by the kidney. Vasopressin allows the concentration of nitrogenous end products (urea, ammonia, etc.) and other protein-associated wastes in a hyperosmotic urine, thus allowing a very significant water economy characteristic of all terrestrial mammals. No hyperfiltration occurs in the absence of one or the other hormone. Experimental results suggest that the combined actions of these two hormones, along with the complex intrarenal handling of urea, lead to alter the composition of the tubular fluid at the macula densa and to reduce the intensity of the signal activating the tubuloglomerular feedback control of GFR, thus allowing GFR to raise. Altogether, glucagon, vasopressin, and urea contribute to set up the best compromise between efficient urea excretion and water economy.
引用
收藏
页码:F2 / F23
页数:22
相关论文
共 261 条
  • [1] ADDIS T, 1940, T ASSOC AM PHYSICIAN, V55, P223
  • [2] INFLUENCE OF GLUCAGON ON GFR AND ON UREA AND ELECTROLYTE EXCRETION - DIRECT AND INDIRECT EFFECTS
    AHLOULAY, M
    DECHAUX, M
    LABORDE, K
    BANKIR, L
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 269 (02): : F225 - F235
  • [3] Ahloulay Mina, 1996, Journal of the American Society of Nephrology, V7, P1868
  • [4] EFFECTS OF GLUCAGON ON GLOMERULAR-FILTRATION RATE AND UREA AND WATER-EXCRETION
    AHLOULAY, M
    BOUBY, N
    MACHET, F
    KUBRUSLY, M
    COUTAUD, C
    BANKIR, L
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (01): : F24 - F36
  • [5] Ahloulay M, 1999, DIABETES METAB, V25, P213
  • [6] Cyclic AMP is a hepatorenal link influencing natriuresis and contributing to glucagon-induced hyperfiltration in rats
    Ahloulay, M
    Dechaux, M
    Hassler, C
    Bouby, N
    Bankir, L
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (10) : 2251 - 2258
  • [7] Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes
    Ali, Safina
    Drucker, Daniel J.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 296 (03): : E415 - E421
  • [8] LOSS OF NITROGEN FROM ORGANS IN RATS INDUCED BY EXOGENOUS GLUCAGON
    ALMDAL, TP
    VILSTRUP, H
    [J]. ENDOCRINOLOGY, 1988, 123 (05) : 2182 - 2186
  • [9] INCREASED AMINO-ACID CLEARANCE AND UREA SYNTHESIS IN A PATIENT WITH GLUCAGONOMA
    ALMDAL, TP
    HEINDORFF, H
    BARDRAM, L
    VILSTRUP, H
    [J]. GUT, 1990, 31 (08) : 946 - 948
  • [10] ALMDAL TP, 1988, DIABETOLOGIA, V31, P836